Garland J. Scott
Insider CIK 1533228 · PTLA President and CEO, Director · RLYP SVP & Chief Commercial Officer · CALA Director · KPTI Director · ELVN Director · LBRX Director · OLMA Director · ALXO Director · DAWN Director · EXEL EVP & Chief Commerical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-05 | 13,000 | — | $0 | 46,372 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-05 | 13,000 | $46.67 | $606.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-10-01 | 2026-10-05 | 13,000 | $15.47 | $201.1K | 13,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-06-18 | 2026-06-23 | 29,500 | — | $0 | 29,500 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2026-06-03 | 2026-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 48,072 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 28,700 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 37,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 22,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 15,000 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 1,427 | — | $0 | 1,427 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2026-01-20 | 2026-01-21 | 40,400 | — | $0 | 40,400 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-01-07 | 2026-01-09 | 59,372 | — | $0 | 59,372 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 48,072 | — | $0 | 48,072 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 48,072 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 28,700 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 28,700 | — | $0 | 28,700 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 37,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 32,335 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2025-09-10 | 2025-09-12 | 22,449 | — | $0 | 22,449 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2025-09-10 | 2025-09-12 | 3,585 | — | $0 | 3,585 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | D To issuer deriv | 2025-09-10 | 2025-09-12 | 3,585 | — | $0 | 0 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2025-09-10 | 2025-09-12 | 17,929 | — | $0 | 17,929 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | D To issuer deriv | 2025-09-10 | 2025-09-12 | 17,929 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 24,150 | — | $0 | 24,150 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-01-21 | 2025-01-23 | 40,400 | — | $0 | 40,400 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,000 | — | $0 | 23,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2024-06-13 | 2024-06-14 | 20,200 | — | $0 | 20,200 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-05-23 | 2024-05-28 | 32,335 | — | $0 | 32,335 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2023-10-16 | 2023-10-17 | 14,347 | — | $0 | 14,347 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2023-10-16 | 2023-10-17 | 21,520 | — | $0 | 21,520 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2023-06-22 | 2023-06-26 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2023-06-20 | 2023-06-22 | 10,100 | — | $0 | 10,100 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2022-11-28 | 2022-11-29 | 24,009 | — | $0 | 24,009 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2022-06-21 | 2022-06-23 | 28,700 | — | $0 | 28,700 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2022-06-01 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2021-08-16 | 2021-08-18 | 48,072 | — | $0 | 48,072 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | A Award deriv | 2020-07-31 | 2020-08-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 200,000 | $5.21 | $1.04M | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 100,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 50,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 100,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 153,399 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 370,400 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 1,173 | $18.00 | $21.1K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 24,529 | $18.00 | $441.5K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-06-18 | 2020-07-02 | 1,173 | $8.36 | $9.8K | 1,173 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-02-24 | 2020-02-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2020-02-03 | 2020-02-04 | 5,623 | $12.89 | $72.5K | 177,928 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-01-31 | 2020-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-01-31 | 2020-02-04 | 50,000 | — | $0 | 183,551 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2019-11-01 | 2019-11-04 | 21,549 | $29.84 | $643.0K | 133,551 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-06-06 | 2019-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2019-01-31 | 2019-02-04 | 120,400 | — | $0 | 120,400 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-01-31 | 2019-02-04 | 30,100 | — | $0 | 155,100 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2018-10-31 | 2018-10-31 | 250,000 | — | $0 | 250,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2018-10-31 | 2018-10-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2018-06-19 | 2018-06-20 | 17,000 | — | $0 | 17,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2017-06-15 | 2017-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 100,000 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 35,000 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-09-01 | 2016-09-02 | 16,667 | — | $0 | 25,000 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 25,000 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | U Tender | 2016-09-01 | 2016-09-02 | 2,470 | $32.00 | $79.0K | 16,042 | SEC↗ |
| RLYP Relypsa Inc | D To issuer | 2016-09-01 | 2016-09-02 | 16,042 | $32.00 | $513.3K | 0 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-09-01 | 2016-09-02 | 4,167 | — | $0 | 18,512 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2016-08-15 | 2016-08-17 | 705 | $31.89 | $22.5K | 14,345 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2016-06-16 | 2016-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-06-03 | 2016-06-07 | 8,333 | — | $0 | 8,333 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2016-06-03 | 2016-06-07 | 783 | $19.96 | $15.6K | 15,050 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-06-03 | 2016-06-07 | 2,083 | — | $0 | 15,833 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-11-06 | 2015-11-10 | 6,250 | — | $0 | 13,750 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2015-08-10 | 2015-08-12 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-08-10 | 2015-08-12 | 7,500 | — | $0 | 7,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2015-05-22 | 2015-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2014-11-17 | 2014-11-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2014-11-03 | 2014-11-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2013-09-18 | 2013-09-19 | 150,000 | — | $0 | 150,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2012-09-21 | 2012-09-21 | 123,000 | — | $0 | 123,000 | SEC↗ |